cetylpyridinium has been researched along with Mucopolysaccharidosis I in 2 studies
Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
Mucopolysaccharidosis I: Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Whitley, CB | 1 |
| Ridnour, MD | 1 |
| Draper, KA | 1 |
| Dutton, CM | 1 |
| Neglia, JP | 1 |
| Kint, JA | 1 |
2 other studies available for cetylpyridinium and Mucopolysaccharidosis I
| Article | Year |
|---|---|
Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion.
Topics: Bone Marrow Transplantation; Boric Acids; Carbazoles; Cetylpyridinium; Coloring Agents; Female; Glyc | 1989 |
In vitro restoration of deficient beta-galactosidase activity in liver of patients with Hurler and Hunter disease.
Topics: Albumins; Cetylpyridinium; Dose-Response Relationship, Drug; Galactosidases; Humans; In Vitro Techni | 1974 |